Clinical Trials Logo

Clinical Trial Summary

Central retinal artery occlusion (CRAO) is an ophthalmologic emergency which leads to severe and permanent vision loss. There is no evidence-based therapy for CRAO. The objective of this GION study is to evaluate the efficacy and safety of KUS121 intravitreal (IVT) injection in participants with acute non-arteritic CRAO.


Clinical Trial Description

This is a Phase II, double-masked, sham-controlled, multi-center, parallel-group study to evaluate the efficacy and safety of KUS121 intravitreal (IVT) injection in patients with non-arteritic Central Retinal Artery Occlusion (CRAO) diagnosed and treated within 3-48 hours of disease onset. Participants will be randomized to high dose KUS121, low dose KUS121, or sham in a 1:1:1 ratio. Participants will receive daily intravitreal injections of KUS 121 or sham, which mimics an injection, from Day 1 through Day 3. Primary efficacy endpoint is the proportion of participants who gain 15 letters or more in BCVA compared with baseline and will be assessed at Week 12. Safety evaluation will continue until a 12-month follow up. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06178055
Study type Interventional
Source Kyoto Drug Discovery and Development Co., Ltd.
Contact Kyoto Drug Discovery & Development Clinical Trials Contact
Phone (+81) 6-7777-1003
Email clinical@kyoto-drug.com
Status Recruiting
Phase Phase 2
Start date April 16, 2024
Completion date September 2025

See also
  Status Clinical Trial Phase
Completed NCT02390245 - Philadelphia Telemedicine Glaucoma Detection and Follow-Up Study N/A
Recruiting NCT04526951 - TENecteplase in Central Retinal Artery Occlusion Stuy (TenCRAOS) Phase 3
Recruiting NCT04965038 - Early Reperfusion Therapy With Intravenous Alteplase for Recovery of VISION in Acute Central Retinal Artery Occlusion Phase 3
Recruiting NCT01348633 - Retinal Oxygen Saturation, Blood Flow, Vascular Function and High Resolution Morphometric Imaging in the Living Human Eye N/A
Completed NCT03197194 - A Phase III Randomized, Blind, Double Dummy, Multicenter Study Assessing the Efficacy and Safety of IV THrombolysis (Alteplase) in Patients With acutE Central retInal Artery Occlusion Phase 3
Recruiting NCT05562284 - Safety and Efficacy After Selective Intra-arterial Thrombolysis for Central Retinal Artery Occlusion N/A
Completed NCT05739487 - Changes of Visual Field Defects After IAT for CRAO
Completed NCT03049514 - Study of Arterial Recanalization of the Central Retinal Artery Occlusions
Recruiting NCT00802698 - The Effect of Transcorneal Stimulation in Cases of Central Retinal Artery Occlusion Using a New Waveform Phase 1/Phase 2